First Trust Direct Indexing L.P. Has $1.27 Million Stake in Humana Inc. (NYSE:HUM)

First Trust Direct Indexing L.P. trimmed its position in shares of Humana Inc. (NYSE:HUM) by 8.7% during the third quarter, Holdings Channel.com reports. The institutional investor owned 4,011 shares of the insurance provider’s stock after selling 382 shares during the period. First Trust Direct Indexing L.P.’s holdings in Humana were worth $1,270,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Norden Group LLC boosted its position in Humana by 137.9% during the first quarter. Norden Group LLC now owns 1,130 shares of the insurance provider’s stock worth $392,000 after purchasing an additional 655 shares during the period. J.W. Cole Advisors Inc. bought a new position in Humana during the first quarter worth $281,000. Diversify Advisory Services LLC bought a new position in Humana during the first quarter worth $1,195,000. Mirae Asset Global Investments Co. Ltd. boosted its position in Humana by 9.2% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 41,412 shares of the insurance provider’s stock worth $14,358,000 after purchasing an additional 3,501 shares during the period. Finally, Kinsale Capital Group Inc. boosted its position in Humana by 42.7% during the first quarter. Kinsale Capital Group Inc. now owns 7,484 shares of the insurance provider’s stock worth $2,595,000 after purchasing an additional 2,240 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Humana stock opened at $257.83 on Friday. The stock has a market capitalization of $31.07 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 2.04 and a beta of 0.50. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The stock’s 50 day moving average price is $298.90 and its two-hundred day moving average price is $334.81. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. On average, equities analysts predict that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio is currently 22.04%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. UBS Group reduced their target price on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, October 4th. Stephens reaffirmed an “equal weight” rating and set a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Finally, Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $392.00 to $274.00 in a research report on Thursday, October 3rd. One research analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $315.48.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.